These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 37186601)
1. The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD). Allen NM; O'Rahelly M; Eymard B; Chouchane M; Hahn A; Kearns G; Kim DS; Byun SY; Nguyen CE; Schara-Schmidt U; Kölbel H; Marina AD; Schneider-Gold C; Roefke K; Thieme A; Van den Bergh P; Avalos G; Álvarez-Velasco R; Natera-de Benito D; Cheng MHM; Chan WK; Wan HS; Thomas MA; Borch L; Lauzon J; Kornblum C; Reimann J; Mueller A; Kuntzer T; Norwood F; Ramdas S; Jacobson LW; Jie X; Fernandez-Garcia MA; Wraige E; Lim M; Lin JP; Claeys KG; Aktas S; Oskoui M; Hacohen Y; Masud A; Leite MI; Palace J; De Vivo D; Vincent A; Jungbluth H Brain; 2023 Oct; 146(10):4233-4246. PubMed ID: 37186601 [TBL] [Abstract][Full Text] [Related]
2. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Polizzi A; Huson SM; Vincent A Teratology; 2000 Nov; 62(5):332-41. PubMed ID: 11029151 [TBL] [Abstract][Full Text] [Related]
4. Maternal immunoglobulin treatment can reduce severity of fetal acetylcholine receptor antibody-associated disorders (FARAD). Wassenberg M; Hahn A; Mück A; Krämer HH Neurol Res Pract; 2023 Oct; 5(1):58. PubMed ID: 37880783 [TBL] [Abstract][Full Text] [Related]
5. Fetal acetylcholine receptor inactivation syndrome: A myopathy due to maternal antibodies. Hacohen Y; Jacobson LW; Byrne S; Norwood F; Lall A; Robb S; Dilena R; Fumagalli M; Born AP; Clarke D; Lim M; Vincent A; Jungbluth H Neurol Neuroimmunol Neuroinflamm; 2015 Feb; 2(1):e57. PubMed ID: 25566546 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany. Draxler J; Meisel A; Stascheit F; Stein M; Gerischer L; Mergenthaler P; Herdick M; Doksani P; Lehnerer S; Verlohren S; Hoffmann S Arch Gynecol Obstet; 2024 Jul; 310(1):277-284. PubMed ID: 38492082 [TBL] [Abstract][Full Text] [Related]
7. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita. Vincent A; Jacobson L; Plested P; Polizzi A; Tang T; Riemersma S; Newland C; Ghorazian S; Farrar J; MacLennan C; Willcox N; Beeson D; Newsom-Davis J Ann N Y Acad Sci; 1998 May; 841():482-96. PubMed ID: 9668280 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen. Matthews I; Sims G; Ledwidge S; Stott D; Beeson D; Willcox N; Vincent A Lab Invest; 2002 Oct; 82(10):1407-17. PubMed ID: 12379775 [TBL] [Abstract][Full Text] [Related]
9. Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence. Gilhus NE; Hong Y Eur J Neurol; 2018 Dec; 25(12):1402-1409. PubMed ID: 30133097 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis. Iijima S Pediatr Neonatol; 2021 Nov; 62(6):581-590. PubMed ID: 34272198 [TBL] [Abstract][Full Text] [Related]
11. Antibodies in myasthenia gravis and related disorders. Vincent A; McConville J; Farrugia ME; Bowen J; Plested P; Tang T; Evoli A; Matthews I; Sims G; Dalton P; Jacobson L; Polizzi A; Blaes F; Lang B; Beeson D; Willcox N; Newsom-Davis J; Hoch W Ann N Y Acad Sci; 2003 Sep; 998():324-35. PubMed ID: 14592891 [TBL] [Abstract][Full Text] [Related]
12. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Vincent A; Newland C; Brueton L; Beeson D; Riemersma S; Huson SM; Newsom-Davis J Lancet; 1995 Jul; 346(8966):24-5. PubMed ID: 7603140 [TBL] [Abstract][Full Text] [Related]